We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

135 hedge funds and large institutions have $1.09B invested in Genomic Health, Inc. in 2017 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,493% more call options, than puts

Call options by funds: $3.22M | Put options by funds: $202K

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

14% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 42

8% more capital invested

Capital invested by funds: $1.01B → $1.09B (+$76.9M)

5% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 20

1% more funds holding

Funds holding: 134 → 135 (+1)

Holders
135
Holders Change
+1
Holders Change %
+0.75%
% of All Funds
3.06%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
21
Increased
48
Reduced
42
Closed
20
Calls
$3.22M
Puts
$202K
Net Calls
+$3.02M
Net Calls Change
+$3.02M

Top Buyers

Rank Fund Capital Flow
1
CWAM
Columbia Wanger Asset Management
Illinois
+$14.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.9M
3
Renaissance Technologies
Renaissance Technologies
New York
+$4.51M
4
State Street
State Street
Massachusetts
+$3.22M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$2.86M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$7.94M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$4.84M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.88M
4
SIM
Spark Investment Management
New York
-$1.69M
5
Charles Schwab
Charles Schwab
California
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
AQR Capital Management
26
AQR Capital Management
Connecticut
$4.83M +$913K +28,639 +25%
Bank of America
27
Bank of America
North Carolina
$4.79M +$47.5K +1,489 +1%
MFAM
28
Motley Fool Asset Management
Virginia
$4.51M – – –
Morgan Stanley
29
Morgan Stanley
New York
$4.1M -$502K -15,742 -12%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$4.01M +$590K +18,516 +19%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$3.83M -$459K -14,382 -11%
First Manhattan
32
First Manhattan
New York
$3.79M +$1.3M +40,900 +58%
CPA
33
Cowen Prime Advisors
New York
$3.78M -$455K -14,266 -11%
Citadel Advisors
34
Citadel Advisors
Florida
$3.38M +$164K +5,130 +5%
Ameriprise
35
Ameriprise
Minnesota
$3.35M +$357K +11,192 +13%
UONDDL
36
University of Notre Dame du Lac
Indiana
$3.16M +$312K +9,776 +12%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$3.12M +$18K +564 +0.6%
Skandinaviska Enskilda Banken (SEB)
38
Skandinaviska Enskilda Banken (SEB)
Sweden
$3.11M -$239K -7,500 -8%
PAMU
39
Pictet Asset Management (UK)
United Kingdom
$3.06M +$2.86M +89,600 New
CS
40
Candriam SCA
Luxembourg
$3.04M -$319K -10,000 -10%
Wells Fargo
41
Wells Fargo
California
$2.99M +$588K +18,441 +27%
SIM
42
Spark Investment Management
New York
$2.82M -$1.69M -53,100 -39%
Nordea Investment Management
43
Nordea Investment Management
Sweden
$2.76M +$379K +11,901 +17%
Allianz Asset Management
44
Allianz Asset Management
Germany
$2.59M +$2.41M +75,675 New
SI
45
Scout Investments
Missouri
$2.51M +$12.8K +400 +0.5%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$2.51M -$602K -18,874 -20%
OC
47
Oppenheimer & Co
New York
$2.45M – – –
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$2.17M -$21.6K -676 -1%
EU
49
Emory University
Georgia
$2.15M +$302K +9,487 +18%
UBS Group
50
UBS Group
Switzerland
$2.1M +$59.4K +1,862 +3%
1
2
3 4 5

GHDX Hedge Fund Activity: Q4 2017 in Review

135 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q4 2017, worth a combined $1.09B — up 7.6% from $1.01B a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new GHDX positions and 20 closed out — a net gain of 1 holder — while 48 added to existing stakes and 42 trimmed.

The largest buyer was Columbia Wanger Asset Management, adding an estimated $14.2M. The largest seller was BlackRock, cutting an estimated $7.94M.

  • 135 institutional investors held Genomic Health, Inc. (GHDX) as of Q4 2017, up from 134 in Q3 2017.
  • Funds reported $1.09B of Genomic Health, Inc. stock for Q4 2017, up 7.6% quarter-over-quarter.
  • 21 funds opened new Genomic Health, Inc. positions in Q4 2017 and 20 closed out, a net change of +1 holder.
  • The largest Genomic Health, Inc. buyer in Q4 2017 was Columbia Wanger Asset Management, an estimated $14.2M added.
  • The largest Genomic Health, Inc. seller in Q4 2017 was BlackRock, an estimated $7.94M sold.

Based on aggregated 13F filings for Q4 2017.